Rynki

Twoje finanse

Biznes

Forum

SOPHARMA AD: Notification from Rositsa Doneva in accordance with Regulation 596/2014 for transactions with shares of "Sopharma" AD

Spis treści:

1. REPORT

reklama

2. INFORMATION ABOUT THE ENTITY

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY


Spis załączników:
RDoneva Sopharma EN 03092025.pdf  (REPORT)

przewiń, aby zobaczyć całą tabelę
POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No 138 / 2025
Date of issue: 2025-09-04
Short name of the issuer
SOPHARMA AD
Subject
Notification from Rositsa Doneva in accordance with Regulation 596/2014 for transactions with shares of "Sopharma" AD
Official market - legal basis
Art. 56. 1. 2 of Act on Public Offering
Unofficial market - legal basis
Contents of the report:
Notification from Rositsa Doneva in accordance with Regulation 596/2014 for transactions with shares of "Sopharma" AD
Annexes
File Description
RDoneva Sopharma EN 03092025.pdfRDoneva_Sopharma_EN_03092025.pdf Notification from Rositsa Doneva in accordance with Regulation 596/2014 for transactions with shares of "Sopharma" AD

przewiń, aby zobaczyć całą tabelę
SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

przewiń, aby zobaczyć całą tabelę
SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2025-09-04 Ognian Ivanov Donev Executive Director
Źródło: Komunikaty spółek (ESPI)
powiązane
polecane
najnowsze
popularne
najnowsze
bankier na skróty